Biomimetic reconstruction of the hematopoietic stem cell niche for in vitro amplification of human hematopoietic stem cells.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 20 03 2020
accepted: 29 05 2020
entrez: 23 6 2020
pubmed: 23 6 2020
medline: 28 8 2020
Statut: epublish

Résumé

Hematopoietic stem cell transplantation is successfully applied since the late 1950s; however, its efficacy still needs to be increased. A promising strategy is to transplant high numbers of pluripotent hematopoietic stem cells (HSCs). Therefore, an improved ex vivo culture system that supports proliferation and maintains HSC pluripotency would override possible limitations in cell numbers gained from donors. To model the natural HSC niche in vitro, we optimized the HSC medium composition with a panel of cytokines and valproic acid and used an artificial 3D bone marrow-like scaffold made of polydimethylsiloxane (PDMS). This 3D scaffold offered a suitable platform to amplify human HSCs in vitro and, simultaneously, to support their viability, multipotency and ability for self-renewal. Silicon oxide-covering of PDMS structures further improved amplification of CD34+ cells, although the conservation of naïve HSCs was better on non-covered 3D PDMS. Finally, we found that HSC cultivated on non-covered 3D PDMS generated most pluripotent colonies within colony forming unit assays. In conclusion, by combining biological and biotechnological approaches, we optimized in vitro HSCs culture conditions, resulting in improved amplification, multipotency maintenance and vitality of HSCs.

Identifiants

pubmed: 32569325
doi: 10.1371/journal.pone.0234638
pii: PONE-D-20-08015
pmc: PMC7307768
doi:

Substances chimiques

Dimethylpolysiloxanes 0
Fibronectins 0
Purines 0
StemRegenin 1 0
Valproic Acid 614OI1Z5WI
baysilon 63148-62-9
Collagen 9007-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0234638

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biochem Biophys Res Commun. 2006 Dec 1;350(4):1000-5
pubmed: 17045241
Biomaterials. 2011 Oct;32(29):7060-7
pubmed: 21724252
Nat Biotechnol. 2005 Jan;23(1):47-55
pubmed: 15637621
Biomaterials. 2009 Oct;30(28):5241-50
pubmed: 19545891
Artif Cells Nanomed Biotechnol. 2018 Aug;46(5):1025-1033
pubmed: 28782391
Adv Drug Deliv Rev. 2008 Jan 14;60(2):215-28
pubmed: 17997187
Cancer Res. 2005 Feb 15;65(4):1505-13
pubmed: 15735039
Bone Marrow Transplant. 2016 Jun;51(6):778-85
pubmed: 26901703
Mol Carcinog. 2013 Mar;52(3):167-82
pubmed: 22162252
J Biomed Mater Res A. 2006 Sep 15;78(4):781-91
pubmed: 16739181
Nat Rev Genet. 2000 Oct;1(1):57-64
pubmed: 11262875
Cell Adh Migr. 2012 Jan-Feb;6(1):39-48
pubmed: 22647939
Curr Opin Biotechnol. 2008 Oct;19(5):534-40
pubmed: 18725291
Ann N Y Acad Sci. 2012 Aug;1266:138-50
pubmed: 22901265
Nature. 2013 Aug 8;500(7461):217-21
pubmed: 23842490
Macromol Rapid Commun. 2012 Sep 14;33(17):1420-31
pubmed: 22887752
Cell Stem Cell. 2016 Jan 7;18(1):144-55
pubmed: 26669897
Lab Chip. 2012 Apr 7;12(7):1224-37
pubmed: 22318426
Cancer Res. 2005 Apr 1;65(7):2537-41
pubmed: 15805245
Leukemia. 2014 Oct;28(10):2097-101
pubmed: 24903478
Nature. 2018 Jan 24;553(7689):418-426
pubmed: 29364285
J Hematother Stem Cell Res. 2001 Jun;10(3):355-68
pubmed: 11454311
Nature. 2003 Oct 23;425(6960):836-41
pubmed: 14574412
Cell. 2008 Feb 22;132(4):631-44
pubmed: 18295580
Blood. 2004 Jun 1;103(11):4344-52
pubmed: 14976038
J Clin Invest. 2014 Jun;124(6):2378-95
pubmed: 24762436
Methods Mol Biol. 2014;1130:315-324
pubmed: 24482184
Nature. 2019 Jul;571(7766):E12
pubmed: 31289376
Cell Stem Cell. 2012 Feb 3;10(2):120-36
pubmed: 22305562
Science. 2010 Sep 10;329(5997):1345-8
pubmed: 20688981

Auteurs

L Marx-Blümel (L)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.
Research Center Lobeda, Jena University Hospital, Jena, Germany.

C Marx (C)

Leibniz Institute on Aging-Fritz Lipmann Institute (FLI), Jena, Germany.

F Weise (F)

Institute for Micro and Nanotechnologies MacroNano®, Nano-Biosystem Technology, Ilmenau University of Technology, Ilmenau, Germany.

J Frey (J)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.
Research Center Lobeda, Jena University Hospital, Jena, Germany.

B Perner (B)

Leibniz Institute on Aging-Fritz Lipmann Institute (FLI), Jena, Germany.

G Schlingloff (G)

Institute for Micro and Nanotechnologies MacroNano®, Nano-Biosystem Technology, Ilmenau University of Technology, Ilmenau, Germany.

N Lindig (N)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.
Research Center Lobeda, Jena University Hospital, Jena, Germany.

J Hampl (J)

Institute for Micro and Nanotechnologies MacroNano®, Nano-Biosystem Technology, Ilmenau University of Technology, Ilmenau, Germany.

J Sonnemann (J)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.
Research Center Lobeda, Jena University Hospital, Jena, Germany.

D Brauer (D)

Institute for Micro and Nanotechnologies MacroNano®, Nano-Biosystem Technology, Ilmenau University of Technology, Ilmenau, Germany.

A Voigt (A)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.
Research Center Lobeda, Jena University Hospital, Jena, Germany.

S Singh (S)

Institute for Micro and Nanotechnologies MacroNano®, Nano-Biosystem Technology, Ilmenau University of Technology, Ilmenau, Germany.

B Beck (B)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.
Research Center Lobeda, Jena University Hospital, Jena, Germany.

Ute-Maria Jäger (UM)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.
Research Center Lobeda, Jena University Hospital, Jena, Germany.

Z Q Wang (ZQ)

Leibniz Institute on Aging-Fritz Lipmann Institute (FLI), Jena, Germany.
Faculty of Biological Sciences, Friedrich-Schiller-University of Jena, Jena, Germany.

J F Beck (JF)

Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.

A Schober (A)

Institute for Micro and Nanotechnologies MacroNano®, Nano-Biosystem Technology, Ilmenau University of Technology, Ilmenau, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH